Showing results (331-340 of 439) with videos related to

Sort By:
Pageof 44
European Urology|May 17, 2019
Molecular Subtyping of Clinically Localized Urothelial Carcinoma Reveals Lower Rates of Pathological Upstaging at Radical Cystectomy Among Luminal TumorsYair Lotan, Stephen A Boorjian, Jingbin Zhang, et al.
JCO Precision Oncology|November 5, 2024
DNA Damage Response Alterations Predict for Neoadjuvant Chemotherapy Sensitivity in Muscle-Invasive Bladder Cancer: A Correlative Analysis of the SWOG S1314 TrialGopa Iyer, Catherine M Tangen, Michal Sarfaty, et al.
BJU International|September 14, 2007
Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survivalPatrick J Bastian, Georg C Hutterer, Shahrokh F Shariat, et al.
European Urology|November 23, 2006
Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomyMatthew E Nielsen, Shahrokh F Shariat, Pierre I Karakiewicz, et al.
Human Mutation|April 17, 2009
Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype-phenotype correlationsJordan P Lerner-Ellis, Natascia Anastasio, Junhui Liu, et al.
Neuroradiology|July 8, 2025
Prognostic value of cerebral venous outflow profiles for outcomes prediction following reperfusion therapy in acute ischemic stroke: a meta-analysisHesham Kelani, Mohamed R Abdelraouf, Shree Rath, et al.
JAMA Network Open|August 6, 2024
Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical TrialShuchi Gulati, Catherine Tangen, Christopher W Ryan, et al.
JAMA Network Open|July 9, 2024
Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer: A Secondary Analysis of the SWOG-1216 TrialGeorges Gebrael, Yeonjung Jo, Umang Swami, et al.
BJU International|December 17, 2013
Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomesRichard K Lee, Hassan Abol-Enein, Walter Artibani, et al.
Urology|December 17, 2013
Clinical trial design for the development of new therapies for nonmuscle-invasive bladder cancer: report of a Food and Drug Administration and American Urological Association public workshopJonathan P Jarow, Seth P Lerner, Paul G Kluetz, et al.
Pageof 44